Recombinant multi-species BAP31/BCAP31 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BAP31/BCAP31 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the B-cell receptor associated protein 31 superfamily. The encoded protein is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in caspase 8-mediated apoptosis. Microdeletions in this gene are associated with contiguous ABCD1/DXS1375E deletion syndrome (CADDS), a neonatal disorder. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 16. [provided by RefSeq, Jan 2012]
The Alternative Names of target: 6C6-AG,6C6-AG tumor-associated antigen,B-cell receptor-associated protein 31,BAP31,BCAP31,BCR-associated protein 31,Bap31,Bcap31,CDM,DDCH,DELXQ28,DXS1357E,MICRODELXq28,Protein CDM,p28

Target products collectionGo to BAP31/BCAP31 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0414-Ag-1/ GM-Tg-hg-IP0414-Ag-2 Human BAP31/BCAP31 protein Human
GM-Tg-rg-IP0414-Ag-1/ GM-Tg-rg-IP0414-Ag-2 Rat BAP31/BCAP31 protein Rat
GM-Tg-mg-IP0414-Ag-1/ GM-Tg-mg-IP0414-Ag-2 Mouse BAP31/BCAP31 protein Mouse
GM-Tg-cynog-IP0414-Ag-1/ GM-Tg-cynog-IP0414-Ag-2 Cynomolgus/Rhesus macaque BAP31/BCAP31 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0414-Ag-1/ GM-Tg-felg-IP0414-Ag-2 Feline BAP31/BCAP31 protein Feline
GM-Tg-cang-IP0414-Ag-1/ GM-Tg-cang-IP0414-Ag-2 Canine BAP31/BCAP31 protein Canine
GM-Tg-bovg-IP0414-Ag-1/ GM-Tg-bovg-IP0414-Ag-2 Bovine BAP31/BCAP31 protein Bovine
GM-Tg-equg-IP0414-Ag-1/ GM-Tg-equg-IP0414-Ag-2 Equine BAP31/BCAP31 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0414-Ag-1/ GM-Tg-hg-IP0414-Ag-2; GM-Tg-rg-IP0414-Ag-1/ GM-Tg-rg-IP0414-Ag-2;
GM-Tg-mg-IP0414-Ag-1/ GM-Tg-mg-IP0414-Ag-2; GM-Tg-cynog-IP0414-Ag-1/ GM-Tg-cynog-IP0414-Ag-2;
GM-Tg-felg-IP0414-Ag-1/ GM-Tg-felg-IP0414-Ag-2; GM-Tg-cang-IP0414-Ag-1/ GM-Tg-cang-IP0414-Ag-2;
GM-Tg-bovg-IP0414-Ag-1/ GM-Tg-bovg-IP0414-Ag-2; GM-Tg-equg-IP0414-Ag-1/ GM-Tg-equg-IP0414-Ag-2
Products Name BAP31/BCAP31 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name BAP31/BCAP31
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BAP31/BCAP31 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.